Our study confirmed that SFN may prevent the imbalance of Th17/Treg cells by inhibiting the PI3K/AKt/GSK-3β signaling pathway, thereby alleviating intestinal injury to protect against NEC. The gene discussed is GSK3B; the disease is necrotizing enterocolitis.